India Pharmas Urge Anti-Dumping Duties On Imported Chinese APIs
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are urging the government to take action against what they consider Chinese companies “dumping” drugs on the Indian market to draw customers to lower prices.